• Something wrong with this record ?

Itraconazole cis-diastereoisomers activate aryl hydrocarbon receptor AhR and pregnane X receptor PXR and induce CYP1A1 in human cell lines and human hepatocytes

M. Stepankova, B. Pastorkova, P. Bachleda, Z. Dvorak,

. 2017 ; 383 (-) : 40-49. [pub] 20170405

Language English Country Ireland

Document type Journal Article

Triazole antimycotic itraconazole contains in its structure three chiral centres; therefore, it forms eight stereoisomers. Commercial preparations of itraconazole are a mixture of four cis-diastereoisomers. There is much evidence that efficacy, adverse effects, and toxicity of chiral drugs may be stereospecific. Therefore, we have prepared 4 pure cis-diastereoisomers of itraconazole and investigated their effects on transcriptional activities of xenoreceptors aryl hydrocarbon receptor AhR and pregnane X receptor PXR. Gene reporter assays showed that itraconazole dose-dependently activated both AhR and PXR, and the activation of AhR but not of PXR was enantiospecific. Itraconazole diastereoisomers transformed AhR and PXR into their DNA-binding forms, as demonstrated by electromobility shift assays. Cytochrome P450 CYP1A1 mRNA and protein were induced by itraconazole diastereoisomers in human hepatoma cells HepG2, human skin cells HaCaT, and in primary human hepatocytes. The expression of CYP3A4 in human intestinal LS180 cells was not influenced by itraconazole, but we observed downregulation of CYP3A4 in human hepatocytes. Collectively, we show that itraconazole is a dual activator of AhR and PXR, with differential effects on the target genes for xenoreceptors. The enantiospecific pattern was observed only in gene reporter assays for AhR. The data presented here might be of toxicological and clinical importance.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023150
003      
CZ-PrNML
005      
20170720125630.0
007      
ta
008      
170720s2017 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.tox.2017.04.002 $2 doi
035    __
$a (PubMed)28390928
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Stepankova, Martina $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.
245    10
$a Itraconazole cis-diastereoisomers activate aryl hydrocarbon receptor AhR and pregnane X receptor PXR and induce CYP1A1 in human cell lines and human hepatocytes / $c M. Stepankova, B. Pastorkova, P. Bachleda, Z. Dvorak,
520    9_
$a Triazole antimycotic itraconazole contains in its structure three chiral centres; therefore, it forms eight stereoisomers. Commercial preparations of itraconazole are a mixture of four cis-diastereoisomers. There is much evidence that efficacy, adverse effects, and toxicity of chiral drugs may be stereospecific. Therefore, we have prepared 4 pure cis-diastereoisomers of itraconazole and investigated their effects on transcriptional activities of xenoreceptors aryl hydrocarbon receptor AhR and pregnane X receptor PXR. Gene reporter assays showed that itraconazole dose-dependently activated both AhR and PXR, and the activation of AhR but not of PXR was enantiospecific. Itraconazole diastereoisomers transformed AhR and PXR into their DNA-binding forms, as demonstrated by electromobility shift assays. Cytochrome P450 CYP1A1 mRNA and protein were induced by itraconazole diastereoisomers in human hepatoma cells HepG2, human skin cells HaCaT, and in primary human hepatocytes. The expression of CYP3A4 in human intestinal LS180 cells was not influenced by itraconazole, but we observed downregulation of CYP3A4 in human hepatocytes. Collectively, we show that itraconazole is a dual activator of AhR and PXR, with differential effects on the target genes for xenoreceptors. The enantiospecific pattern was observed only in gene reporter assays for AhR. The data presented here might be of toxicological and clinical importance.
650    _2
$a antifungální látky $x chemie $x farmakologie $7 D000935
650    _2
$a buněčné linie $7 D002460
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a inhibitory cytochromu P450 CYP3A $x chemie $x farmakologie $7 D065692
650    _2
$a systém (enzymů) cytochromů P-450 $x genetika $x metabolismus $7 D003577
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepatocyty $x účinky léků $x metabolismus $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a itrakonazol $x chemie $x farmakologie $7 D017964
650    _2
$a lidé středního věku $7 D008875
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a receptory aromatických uhlovodíků $x metabolismus $7 D018336
650    _2
$a steroidní receptory $x metabolismus $7 D011987
650    _2
$a stereoizomerie $7 D013237
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pastorkova, Barbora $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.
700    1_
$a Bachleda, Petr $u 2nd Department of Surgery, University Hospital Olomouc, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic.
700    1_
$a Dvorak, Zdenek $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic. Electronic address: moulin@email.cz.
773    0_
$w MED00004533 $t Toxicology $x 1879-3185 $g Roč. 383, č. - (2017), s. 40-49
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28390928 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170720130123 $b ABA008
999    __
$a ok $b bmc $g 1238831 $s 984063
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 383 $c - $d 40-49 $e 20170405 $i 1879-3185 $m Toxicology $n Toxicology $x MED00004533
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...